| Year |
Citation |
Score |
| 2020 |
Wittenberg GM, Greene J, Vértes PE, Drevets WC, Bullmore ET. Major Depressive Disorder Is Associated With Differential Expression of Innate Immune and Neutrophil-Related Gene Networks in Peripheral Blood: A Quantitative Review of Whole-Genome Transcriptional Data From Case-Control Studies. Biological Psychiatry. PMID 32653108 DOI: 10.1016/j.biopsych.2020.05.006 |
0.321 |
|
| 2019 |
Wittenberg GM, Stylianou A, Zhang Y, Sun Y, Gupta A, Jagannatha PS, Wang D, Hsu B, Curran ME, Khan S, Chen G, Bullmore ET, Drevets WC. Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders. Molecular Psychiatry. PMID 31427751 DOI: 10.1038/s41380-019-0471-8 |
0.384 |
|
| 2019 |
Lamers F, Milaneschi Y, Smit JH, Schoevers RA, Wittenberg G, Penninx BWJH. Longitudinal Association Between Depression and Inflammatory Markers: Results From the Netherlands Study of Depression and Anxiety. Biological Psychiatry. PMID 30819515 DOI: 10.1016/J.Biopsych.2018.12.020 |
0.388 |
|
| 2018 |
Lamers F, Milaneschi Y, Smit J, Schoevers R, Wittenberg G, Penninx B. F119. Longitudinal Association Between Depression, Depression Characteristics and Inflammatory Markers: Results From the NESDA Study Biological Psychiatry. 83: S283-S284. DOI: 10.1016/J.Biopsych.2018.02.732 |
0.384 |
|
| 2017 |
Gaspersz R, Lamers F, Wittenberg G, Beekman ATF, van Hemert AM, Schoevers RA, Penninx BWJH. The role of anxious distress in immune dysregulation in patients with major depressive disorder. Translational Psychiatry. 7: 1268. PMID 29217840 DOI: 10.1038/S41398-017-0016-3 |
0.347 |
|
| 2017 |
Leday GGR, Vértes PE, Richardson S, Greene JR, Regan T, Khan S, Henderson R, Freeman TC, Pariante CM, Harrison NA, Perry VH, Drevets WC, Wittenberg GM, Bullmore ET. Replicable and Coupled Changes in Innate and Adaptive Immune Gene Expression in Two Case-Control Studies of Blood Microarrays in Major Depressive Disorder. Biological Psychiatry. PMID 28688579 DOI: 10.1016/J.Biopsych.2017.01.021 |
0.388 |
|
| 2017 |
Sun Y, Wang D, Salvadore G, Hsu B, Curran M, Casper C, Vermeulen J, Kent JM, Singh J, Drevets WC, Wittenberg GM, Chen G. The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman's disease. Brain, Behavior, and Immunity. PMID 28676350 DOI: 10.1016/j.bbi.2017.06.014 |
0.387 |
|
| 2017 |
Sun Y, Wittenberg G, Chen G, Drevets W, Hsu B, Curran M. 300. Improvement in Measures of Depressed Mood and Anhedonia in Two Randomized, Placebo-Controlled Phase III Studies of Sirukumab, a Human Anti-Interleukin-6 Antibody, in Patients with Rheumatoid Arthritis Biological Psychiatry. 81: S123. DOI: 10.1136/Annrheumdis-2017-Eular.3263 |
0.371 |
|
| 2017 |
Gaspersz R, Lamers F, Wittenberg G, Beekman A, van Hemert A, Schoevers R, Penninx B. Anxious Distress is Associated with Increased Immune Dysregulation in Patients with Major Depressive Disorder European Psychiatry. 41: S158-S158. DOI: 10.1016/J.Eurpsy.2017.01.2028 |
0.344 |
|
| 2017 |
Greene J, Lin M, Wang J, Ye J, Wittenberg G. 339. Biclustering of Blood Gene Expression Data Identifies Patient Subtypes with Different Biological Pathologies in Major Depressive Disorder Biological Psychiatry. 81: S139. DOI: 10.1016/J.Biopsych.2017.02.354 |
0.338 |
|
| 2017 |
Yu S, Liu X, Singh J, Palmer J, Salvadore G, Canuso C, Hough D, Drevets WC, Wittenberg G, Chen G. 142. Levels of Immune Factors in Depression Subtypes of Treatment Resistant Depression Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.154 |
0.376 |
|
| 2016 |
Sun Y, Narayan VA, Wittenberg GM. Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disorders. Bmc Pharmacology & Toxicology. 17: 47. PMID 27765060 DOI: 10.1186/s40360-016-0090-9 |
0.359 |
|
| 2016 |
Bagot RC, Cates HM, Purushothaman I, Vialou V, Heller EA, Yieh L, LaBonté B, Peña CJ, Shen L, Wittenberg GM, Nestler EJ. Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression Profiles. Biological Psychiatry. PMID 27569543 DOI: 10.1016/J.Biopsych.2016.06.012 |
0.302 |
|
| 2016 |
Liu Y, Yieh L, Yang T, Drinkenburg W, Peeters P, Steckler T, Narayan VA, Wittenberg G, Ye J. Metabolomic biosignature differentiates melancholic depressive patients from healthy controls. Bmc Genomics. 17: 669. PMID 27549765 DOI: 10.1186/S12864-016-2953-2 |
0.411 |
|
| 2015 |
Hsu B, Wang D, Sun Y, Salvadore G, Singh J, Curran M, Caers I, Drevets W, Wittenberg G, Chen G. SAT0182 Improvement in Measures of Depressed Mood and Anhedonia, and Fatigue, In a Randomized, Placebo-Controlled, Phase 2 Study of Sirukumab, A Human Anti-Interleukin-6 Antibody, In Patients with Rheumatoid Arthritis Annals of the Rheumatic Diseases. 74: 720.3-721. DOI: 10.1136/Annrheumdis-2015-Eular.4081 |
0.365 |
|
| 2015 |
Wang D, Sun Y, Salvadore G, Singh J, Hsu B, Curran M, Caers I, Drevets WC, Wittenberg GM, Chen G. P.2.h.016 Interleukin-6 antibody Sirukumab improves depressive symptoms in a randomized, placebo-controlled, phase 2 study in patients with rheumatoid arthritis European Neuropsychopharmacology. 25. DOI: 10.1016/S0924-977X(15)30625-8 |
0.324 |
|
| 2015 |
Sun Y, Wang D, Salvadore G, Singh J, Casper C, Van Rhee F, Vermeulen J, Caers I, Kent J, Drevets W, Chen G, Wittenberg G. P.2.b.033 Siltuximab improves depressive symptoms in a randomised, placebo-controlled, phase 2 study in patients with multicentric Castlemen's disease European Neuropsychopharmacology. 25: S403-S404. DOI: 10.1016/S0924-977X(15)30532-0 |
0.333 |
|
| 2010 |
Shouval HZ, Wang SS, Wittenberg GM. Spike timing dependent plasticity: a consequence of more fundamental learning rules. Frontiers in Computational Neuroscience. 4. PMID 20725599 DOI: 10.3389/Fncom.2010.00019 |
0.648 |
|
| 2007 |
O'Connor DH, Wittenberg GM, Wang SS. Timing and contributions of pre-synaptic and post-synaptic parameter changes during unitary plasticity events at CA3-CA1 synapses. Synapse (New York, N.Y.). 61: 664-78. PMID 17503487 DOI: 10.1002/syn.20403 |
0.698 |
|
| 2006 |
Wittenberg GM, Wang SS. Malleability of spike-timing-dependent plasticity at the CA3-CA1 synapse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 6610-7. PMID 16775149 DOI: 10.1523/JNEUROSCI.5388-05.2006 |
0.661 |
|
| 2005 |
O'Connor DH, Wittenberg GM, Wang SS. Graded bidirectional synaptic plasticity is composed of switch-like unitary events. Proceedings of the National Academy of Sciences of the United States of America. 102: 9679-84. PMID 15983385 DOI: 10.1073/pnas.0502332102 |
0.681 |
|
| 2005 |
O'Connor DH, Wittenberg GM, Wang SS. Dissection of bidirectional synaptic plasticity into saturable unidirectional processes. Journal of Neurophysiology. 94: 1565-73. PMID 15800079 DOI: 10.1152/jn.00047.2005 |
0.694 |
|
| 2002 |
Wittenberg GM, Sullivan MR, Tsien JZ. Synaptic reentry reinforcement based network model for long-term memory consolidation. Hippocampus. 12: 637-47. PMID 12440578 DOI: 10.1002/Hipo.10102 |
0.608 |
|
| 2002 |
Wittenberg GM, Tsien JZ. An emerging molecular and cellular framework for memory processing by the hippocampus. Trends in Neurosciences. 25: 501-5. PMID 12220877 DOI: 10.1016/S0166-2236(02)02231-2 |
0.36 |
|
| Show low-probability matches. |